About us

Dr. Cary is a co-founder of Mesa Biotech and the inventor of the technology that is the basis of the company’s platform. As CSO, he leads projects for the development of rapid molecular tests. Previously he spent 13 years as a principal investigator and scientist at Los Alamos National Laboratory, leading projects focused on biodefense, pathogen detection, nucleic acid metabolism and microarray gene expression technology.

Pete Bantock is a seasoned executive with international commercial and general management experience. With a colorful career that spans clinical diagnostics, biotechnology and pharmaceuticals, he brings an eclectic perspective to commercializing and operationalizing technologies in a variety of healthcare delivery settings. Pete has rich experience in general management; business strategy; sales; marketing and organizational development. He espouses calm, rational thinking. He also inhabits a positive and civil work environment. Interested in science, medicine, business, people and wellness, he leverages his interests and background to offer strategic commercial leadership in the healthcare arena. Previously, Mr. Bantock held a variety of executive roles at Accelerate Diagnostics including Chief Commercial Officer, Head of Clinical Implementation Solutions and Chief Human Resources & Culture Officer. Prior to Accelerate Diagnostics, he was the SVP and GM of Roche Tissue Diagnostics’ North American Commercial Operations. Previously, he was the GM of Spring Bioscience, a subsidiary of Ventana/Roche. Preceding this, Mr. Bantock held a variety of commercial roles in clinical diagnostics at both Ventana Medical Systems and at Abbott Laboratories. He also spent several years working for Eli Lilly in the pharmaceutical sector. He obtained a Bachelors’ Degree and a Higher Diploma of Education from Rhodes University, South Africa.

Kyla brings game-changing strategic leadership to facilitate and support sustainable growth. She scaled CrossFit’s significant labor growth from 800-15,000 units while maintaining culture and developing talent. She brings analytical rigor to the people function and has built and tracked ROI metrics that are driven by and align with the needs of the business. Her experience as a practicing attorney has brought a more analytical approach to the people function.

Kyla is known for cultivating an environment with a strong sense of community supported by a growth mindset. She encourages her team to use their talents, grow from their mistakes, and models accountability and responsibility. She constantly pushes them to grow, knowing that many tasks are hard before they become easy. Her leadership style is one that is tailored and built upon the most powerful attribute—trust.

Julie Richardson leads the commitment to superior Quality Systems for Mesa Biotech with 20+ years of IVD, Clinical, and Pharma experience in the areas of Development, Manufacturing Technical Support, Validation, and Quality Systems. She held positions of increasing responsibilities at companies such as Hybritech, Gen-Probe, and Teva Pharmaceuticals.

Erik Tyrrell-Knott leverages more than 20 years of experience to lead Mesa Biotech’s business development and strategic alliance efforts. He has a proven track record of building multi-million-dollar businesses and alliances for companies ranging from start-ups to mature global companies. Previously, he held senior leadership positions at EMC, GE, Thermo Fisher and Elsevier Corporation.